Boehringer cans inhaled gene therapy Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M Tue W Th F 17 February, 2026

CGT has fresh momentum from new FDA frameworks and pharma deals, but do the latest advances in science, manufacturing, and regulation actually solve the core challenges? We’re asking the hard questions — join us.

presented by Lessons in Cat­e­go­ry Cre­ation: In Con­ver­sa­tion with Bob­by Aza­mi­an, CEO Tar­sus Phar­ma­ceu­ti­cals

news Ocular Therapeutix’ Axpaxli shows superiority over Eylea, shares sink Boehringer Ingelheim stops work on inhaled cystic fibrosis gene therapy Gilead gets cancer drug from China-based Genhouse for $80M upfront

Client Engagement Mgr - Life Sciences Strategy & Intelligence Sedulo Group United States Vice President, Drug Metabolism & Pharmacokinetics (DMPK) C4 Therapeutics Watertown, MA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

Innovation in biopharmaceuticals: A conversation with Fujifilm leaders sponsored by Fujifilm

After years of rough sledding, biotech investors are getting back to work. Join us for a data-driven look at the field’s top VCs and their strategies for 2026. Get your spot now.

ENDPOINTS PHARMA Pentagon does quick about-face after adding WuXi AppTec to Chinese military list Lilly appeals ruling over retatrutide classification in case that could impact compounders Moderna is noncommittal on 2028 break-even guidance, with flu shot future in flux Lilly stockpiles $1.5B worth of weight loss pill ahead of US approval

in case you missed it 1. Exclusive: Feng Zhang’s epigenetic editing startup shifts focus to siRNA obesity therapies 2. Peer Review Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO 3. PTC Therapeutics withdraws US filing for troubled Duchenne treatment 4. Lundbeck's migraine prevention drug succeeds in Phase 2, advancing new therapy class 5. News Briefing Immunic's private placement; Vertex's cystic fibrosis data in young kids 6. Why Europe barred China from flagship Horizon research programmes 7. Top FDA Scientist Explains Why He Quit After Getting a Promotion From RFK Jr.